LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

AUROPHARMA

NSEBSE
F&O
Aurobindo Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE406A01037· Scrip: 524804
ENहिन्दीગુજરાતીमराठी
1,483.20
55.10 (+3.86%)
6/5/2026, 3:28:22 pm
NSE
1,483.20
55.10
+3.86%
BSE
1,375.80
13.75
+0.00%
1,0171,1231,2301,3361,44305-0506-3008-2610-2412-2202-1904-2805-04
244 trading days · 1Y period
TODAY
Open1,431.00
High1,489.70
Low1,426.10
Prev Close1,428.10
Volume24.07L
Value₹354.1Cr
L: 1,426.10H: 1,489.70
52 WEEK
Low1,016.10
High1,489.70
99% of 52W range
Info
Face Value₹1
Listed2000-07-19
ISININE406A01037
SeriesA
BSE Scrip524804

Key Metrics

1D
-1.09%
1W
-2.79%
1M
+5.08%
3M
+22.52%
6M
+25.00%
Valuation
Mkt Cap₹73646 Cr
Growth (QoQ)
Revenue+2.34%
PAT+3.50%
EPS+4.00%
Profitability
Dividend
Yield0.29%
Growth+166.67%
TTM Revenue
₹25815 Cr
TTM EBITDA
₹5316 Cr
TTM PAT
₹2899 Cr
TTM EPS
₹49.69
Rev/Share
₹444.5

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr1995 Cr3989 Cr5984 Cr7979 Cr22-1223-0323-0923-1224-0324-0624-0924-128.48.612.816.015.55.614.014.6
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-317979 Cr6938 Cr1617 Cr1198 Cr846 Cr14.56
2024-09-307796 Cr6725 Cr1589 Cr1207 Cr817 Cr14.00
2024-06-302460 Cr2079 Cr513 Cr446 Cr329 Cr5.62
2024-03-317580 Cr6351 Cr1597 Cr1243 Cr907 Cr15.51
2023-12-317352 Cr6249 Cr1688 Cr1265 Cr940 Cr16.04
2023-09-307219 Cr6332 Cr1492 Cr1075 Cr752 Cr12.83
2023-03-316473 Cr5872 Cr1081 Cr736 Cr506 Cr8.64
2022-12-316407 Cr5819 Cr1002 Cr681 Cr491 Cr8.38

Shareholding Pattern

CURRENT2026-03-31
51.8%PROMOTER
Promoter51.8%
FII15.2%
DII25.9%
Public48.2%
PROMOTER HOLDING TREND
51.8%24-0651.8%24-0951.8%24-1251.8%25-0351.8%25-0951.8%25-1251.8%26-03

Corporate Actions

Ex-DateTypePurpose
2026-04-17OtherBuy Back
2025-08-08DividendInterim Dividend - Rs 4 Per Share
2024-08-26OtherAnnual General Meeting
2024-07-30OtherBuy Back
2024-02-20DividendInterim Dividend - Rs 1.50 Per Share
2023-11-20DividendInterim Dividend - Rs 3 Per Share
2023-08-22OtherAnnual General Meeting
2023-02-17DividendInterim Dividend - Rs 3 Per Share
2022-07-27OtherAnnual General Meeting
2022-06-06DividendInterim Dividend - Rs 4.50 Per Share
2022-02-18DividendInterim Dividend - Rs 1.50 Per Share
2021-11-17Dividend Interim Dividend - Rs 1.50 Per Share
2021-08-27Dividend Interim Dividend - Rs 1.50 Per Share
2021-08-20Other Annual General Meeting
2021-02-22Dividend Interim Dividend - Rs 1.50 Per Share
2020-11-23Dividend Interim Dividend - Rs 1.25 Per Share
2020-08-21Dividend Annual General Meeting/Interim Dividend - Rs 1.25 Per Share
2020-02-17Dividend Interim Dividend - Rs 1.75 Per Share
2019-11-21Dividend Interim Dividend - Rs 1.25 Per Share
2019-08-21Other Annual General Meeting

Earnings Transcripts

Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
5 Nov 2025NSE15K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
4 Aug 2025NSE14K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
26 May 2025NSE15K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
6 Feb 2025NSE16K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE16K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
27 May 2023NSE14K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated February 3, 2...
10 Feb 2023NSE1K chars
Read →
Aurobindo Pharma Limited has informed the Exchange about Investor Presentation
9 Feb 2023NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, ...
3 Feb 2023NSE2K chars
Read →
Sub: Transcript of Q2FY23 earnings call.Please refer to our letter dated November 8, 2022 wherein we...
18 Nov 2022NSE51K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated November 8, 2...
14 Nov 2022NSE1K chars
Read →
Please refer to our letter dated November 8, 2022 wherein we have intimated the schedule of Investor...
12 Nov 2022NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Re...
8 Nov 2022NSE2K chars
Read →
Further to our letter dated September 6, 2022 informing about the participation in the Kotak Institu...
7 Sept 2022NSE2K chars
Read →
Please refer to our letter dated August 8, 2022 wherein we have intimated the schedule of Investors/...
19 Aug 2022NSE55K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 8, 202...
12 Aug 2022NSE1K chars
Read →
Please refer to our letter dated August 8, 2022 wherein we have intimated the schedule of Investors/...
11 Aug 2022NSE12K chars
Read →
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Re...
8 Aug 2022NSE2K chars
Read →
Please refer to our letter dated May 26, 2022 wherein we have intimated the schedule of Investors/ A...
6 Jun 2022NSE50K chars
Read →
Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated May 26, 2022,...
31 May 2022NSE1K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-05-041,398.001,398.001,367.101,376.007.78L
2026-04-301,392.001,404.001,378.601,389.506.06L
2026-04-291,425.901,433.001,389.301,396.8017.39L
2026-04-281,415.001,430.001,410.301,422.608.48L
2026-04-271,414.901,433.401,386.601,416.709.98L
2026-04-241,436.901,446.001,411.701,413.809.68L
2026-04-231,420.001,459.501,409.101,435.4022.38L
2026-04-221,389.501,425.101,382.401,421.2017.04L
2026-04-211,368.901,401.101,367.101,391.7013.63L
2026-04-201,392.001,392.001,363.501,367.807.07L
2026-04-171,388.901,394.901,375.301,386.0016.12L
2026-04-161,389.901,389.901,368.001,386.5022.54L
2026-04-151,350.001,379.201,345.801,373.9018.30L
2026-04-131,340.001,353.001,333.001,339.8013.78L
2026-04-101,345.001,355.001,336.801,349.409.07L
2026-04-091,335.001,346.701,321.601,340.409.39L
2026-04-081,362.701,363.001,316.801,335.7032.56L
2026-04-071,345.001,357.501,316.001,330.0015.58L
2026-04-021,335.501,338.901,266.101,333.7018.70L
2026-04-011,332.201,359.901,325.901,342.1025.95L
2026-03-271,307.801,327.001,296.001,314.2019.24L
2026-03-251,290.401,330.001,282.101,307.8018.92L
2026-03-241,303.001,310.001,255.401,281.6017.69L
2026-03-201,262.001,297.801,258.301,291.4013.96L
2026-03-191,255.001,269.001,240.001,247.508.17L
2026-03-181,278.001,290.501,265.301,269.0017.00L
2026-03-171,284.901,295.001,275.101,286.006.35L
2026-03-161,302.001,314.001,265.801,279.6014.37L
2026-03-131,304.301,317.801,288.101,296.5016.35L
2026-03-121,308.001,319.801,289.401,311.9021.10L

Frequently Asked Questions

About

Aurobindo Pharma Limited is an Indian multinational pharmaceutical company based in Hyderabad, specializing in manufacturing and marketing high-quality generic and branded pharmaceuticals, active pharmaceutical ingredients, and biosimilars. It operates globally with U.S. headquarters and is recognized for its leadership in the industry, offering a wide range of affordable healthcare solutions while maintaining a strong market position in both domestic and international markets.

Advertisement
BOARD OF DIRECTORS
Girish Paman Vanvari
Independent Director
Savita Mahajan
Independent Director
DEPARTED
Venkat Nageswar Chalasani
Independent Director
DEPARTED
Deepali Pant Joshi
Additional Director

Mutual Fund Holdings

8 funds · bar length = % to NAVBrowse all funds →
hdfc3 schemes
HDFC Mid Cap Fund
2.04%
₹17.4K Cr
HDFC Large and Mid Cap Fund
1.12%
₹2.8K Cr
HDFC NIFTY MIDCAP 150 INDEX FUND
1.04%
₹5 Cr
baroda3 schemes
Baroda BNP Paribas Health and Wellness Fund
0.03%
₹13 Cr
Baroda BNP Paribas NIFTY Midcap 150 Index Fund
0.01%
₹0 Cr
Baroda BNP Paribas Arbitrage Fund
0.00%
₹0 Cr
WCFL-THE WEALTH COMPANY FLEXI CAP FUND
0.02%
₹5 Cr
ppfas1 scheme
Parag Parikh Arbitrage Fund
0.00%
₹2 Cr